Pilot study of rituximab treatment to inhibit HLA [human leukocyte antigen] antibodies in renal allograft recipients
Latest Information Update: 26 Oct 2023
At a glance
- Drugs Rituximab (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 20 Oct 2023 Status has been changed to withdrawn prior to enrolment.
- 07 Jul 2007 New trial record.